(MedPage Today) — Almost three-fourths of patients with biochemically recurrent prostate cancer remained metastasis free at 5 years following salvage radiotherapy (sRT) informed by prostate-specific membrane antigen (PSMA) PET/CT, a retrospective…
Source link
Paradigm Shift for Evaluating, Treating Biochemical Recurrence in Prostate Cancer
By ayoobkk2022
